These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17912434)

  • 1. Combined effect of 2-5A-linked antisense against telomerase RNA and conventional therapies on human malignant glioma cells in vitro and in vivo.
    Iwado E; Daido S; Kondo Y; Kondo S
    Int J Oncol; 2007 Nov; 31(5):1087-95. PubMed ID: 17912434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.
    Komata T; Kondo Y; Koga S; Ko SC; Chung LW; Kondo S
    Gene Ther; 2000 Dec; 7(24):2071-9. PubMed ID: 11223987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy of 2-5A antisense against telomerase RNA and cisplatin for malignant gliomas.
    Kondo Y; Komata T; Kondo S
    Int J Oncol; 2001 Jun; 18(6):1287-92. PubMed ID: 11351264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-5A antisense telomerase RNA therapy for intracranial malignant gliomas.
    Mukai S; Kondo Y; Koga S; Komata T; Barna BP; Kondo S
    Cancer Res; 2000 Aug; 60(16):4461-7. PubMed ID: 10969793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-5A antisense therapy directed against human telomerase RNA inhibits telomerase activity and induces apoptosis without telomere impairment in cervical cancer cells.
    Yatabe N; Kyo S; Kondo S; Kanaya T; Wang Z; Maida Y; Takakura M; Nakamura M; Tanaka M; Inoue M
    Cancer Gene Ther; 2002 Jul; 9(7):624-30. PubMed ID: 12082463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component.
    Kondo Y; Koga S; Komata T; Kondo S
    Oncogene; 2000 Apr; 19(18):2205-11. PubMed ID: 10822370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase RNA inhibition using antisense oligonucleotide against human telomerase RNA linked to a 2',5'-oligoadenylate.
    Kondo Y; Kondo S
    Methods Mol Biol; 2007; 405():97-112. PubMed ID: 18369820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-5A antisense directed against telomerase RNA produces apoptosis in ovarian cancer cells.
    Kushner DM; Paranjape JM; Bandyopadhyay B; Cramer H; Leaman DW; Kennedy AW; Silverman RH; Cowell JK
    Gynecol Oncol; 2000 Feb; 76(2):183-92. PubMed ID: 10637068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of caspase transfer using the human telomerase reverse transcriptase promoter and conventional therapies for malignant glioma cells.
    Takeuchi H; Kanzawa T; Kondo Y; Komata T; Hirohata S; Kyo S; Kondo S
    Int J Oncol; 2004 Jul; 25(1):57-63. PubMed ID: 15201989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human telomerase RNA degradation by 2'-5'-linked oligoadenylate antisense chimeras in a cell-free system, cultured tumor cells, and murine xenograft models.
    Paranjape JM; Xu D; Kushner DM; Okicki J; Lindner DJ; Cramer H; Silverman RH; Leaman DW
    Oligonucleotides; 2006; 16(3):225-38. PubMed ID: 16978086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA.
    Kondo S; Kondo Y; Li G; Silverman RH; Cowell JK
    Oncogene; 1998 Jun; 16(25):3323-30. PubMed ID: 9681832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of bladder cancer cells in vitro and in vivo with 2-5A antisense telomerase RNA.
    Koga S; Kondo Y; Komata T; Kondo S
    Gene Ther; 2001 Apr; 8(8):654-8. PubMed ID: 11320413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of telomerase antisense oligonucleotides simultaneously targeting hTR and hTERT produces synergism of inhibition of telomerase activity and growth in human colon cancer cell line.
    Fu XH; Zhang JS; Zhang N; Zhang YD
    World J Gastroenterol; 2005 Feb; 11(6):785-90. PubMed ID: 15682468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma.
    Rainov NG; Fels C; Droege JW; Schäfer C; Kramm CM; Chou TC
    Cancer Gene Ther; 2001 Sep; 8(9):662-8. PubMed ID: 11593335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense telomerase RNA inhibits the growth of human glioma cells in vitro and in vivo.
    You Y; Pu P; Huang Q; Xia Z; Wang C; Wang G; Yu C; Yu JJ; Reed E; Li QQ
    Int J Oncol; 2006 May; 28(5):1225-32. PubMed ID: 16596239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of telomerase RNA (hTR) in cervical cancer by adenovirus-delivered siRNA.
    Li Y; Li H; Yao G; Li W; Wang F; Jiang Z; Li M
    Cancer Gene Ther; 2007 Aug; 14(8):748-55. PubMed ID: 17479103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thresholds of O6-alkylguanine-DNA alkyltransferase which confer significant resistance of human glial tumor xenografts to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or temozolomide.
    Kokkinakis DM; Bocangel DB; Schold SC; Moschel RC; Pegg AE
    Clin Cancer Res; 2001 Feb; 7(2):421-8. PubMed ID: 11234899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid blockade of telomerase activity and tumor cell growth by the DPL lipofection of ribbon antisense to hTR.
    Bajpai AK; Park JH; Moon IJ; Kang H; Lee YH; Doh KO; Suh SI; Chang BC; Park JG
    Oncogene; 2005 Sep; 24(43):6492-501. PubMed ID: 16170384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense telomerase induced cell growth inhibition, cell cycle arrest and telomerase activity down-regulation in gastric and colon cancer cells.
    Wong SC; Yu H; Moochhala SM; So JB
    Anticancer Res; 2003; 23(1A):465-9. PubMed ID: 12680250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caspase-8 gene therapy using the human telomerase reverse transcriptase promoter for malignant glioma cells.
    Komata T; Kondo Y; Kanzawa T; Ito H; Hirohata S; Koga S; Sumiyoshi H; Takakura M; Inoue M; Barna BP; Germano IM; Kyo S; Kondo S
    Hum Gene Ther; 2002 Jun; 13(9):1015-25. PubMed ID: 12067435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.